These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The cellular metabolism and systemic toxicity of arsenic. Thomas DJ; Styblo M; Lin S Toxicol Appl Pharmacol; 2001 Oct; 176(2):127-44. PubMed ID: 11601889 [TBL] [Abstract][Full Text] [Related]
6. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Schuhmacher-Wolz U; Dieter HH; Klein D; Schneider K Crit Rev Toxicol; 2009; 39(4):271-98. PubMed ID: 19235533 [TBL] [Abstract][Full Text] [Related]
7. New in vitro approaches to explore cellular and molecular events related to carcinogenesis. Fimognari C; Nüsse M; Forti GC; Hrelia P Pharmacol Res; 2000 Apr; 41(4):385-90. PubMed ID: 10704260 [No Abstract] [Full Text] [Related]
8. Physiologically based pharmacokinetic modeling of arsenic in the mouse. Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111 [TBL] [Abstract][Full Text] [Related]
9. Metal ions in human cancer development. Tokar EJ; Benbrahim-Tallaa L; Waalkes MP Met Ions Life Sci; 2011; 8():375-401. PubMed ID: 21473387 [TBL] [Abstract][Full Text] [Related]
10. The enigma of arsenic carcinogenesis: role of metabolism. Goering PL; Aposhian HV; Mass MJ; Cebrián M; Beck BD; Waalkes MP Toxicol Sci; 1999 May; 49(1):5-14. PubMed ID: 10367337 [TBL] [Abstract][Full Text] [Related]
12. Arsenic pesticides and environmental pollution: exposure, poisoning, hazards and recommendations. El-Bahnasawy MM; Mohammad Ael-H; Morsy TA J Egypt Soc Parasitol; 2013 Aug; 43(2):493-508. PubMed ID: 24260828 [TBL] [Abstract][Full Text] [Related]
13. The carcinogenic potential of cadmium, arsenic, and selenium and the associated public health and regulatory implications. Fan AM J Toxicol Sci; 1990 Dec; 15 Suppl 4():162-75. PubMed ID: 2100319 [No Abstract] [Full Text] [Related]
14. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data. Sielken RL; Stevenson DE Prog Clin Biol Res; 1992; 374():295-319. PubMed ID: 1620708 [No Abstract] [Full Text] [Related]
15. Arsenic: in search of an antidote to a global poison. Mead MN Environ Health Perspect; 2005 Jun; 113(6):A378-86. PubMed ID: 15929879 [No Abstract] [Full Text] [Related]
16. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? Simeonova PP; Luster MI J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894 [TBL] [Abstract][Full Text] [Related]
17. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties. Chen C; Farland W Prog Clin Biol Res; 1991; 369():481-99. PubMed ID: 1946541 [No Abstract] [Full Text] [Related]
18. Arsenic as an environmental toxicant and a therapeutic agent: Foe and friend. Xu Y; Tokar EJ; Pi J Toxicol Appl Pharmacol; 2021 Mar; 415():115438. PubMed ID: 33548274 [No Abstract] [Full Text] [Related]
19. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes. Zhou Q; Xi S Regul Toxicol Pharmacol; 2018 Nov; 99():78-88. PubMed ID: 30223072 [TBL] [Abstract][Full Text] [Related]
20. Cancer risks associated with arsenic in drinking water. Guo HR Environ Health Perspect; 2007 Jul; 115(7):A339-40; author reply A340-1. PubMed ID: 17637893 [No Abstract] [Full Text] [Related] [Next] [New Search]